Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: OCGN stock price vs CPB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CPB's multiple
Needs CPB P/S.
Implied fair value · at OCGN's multiple
Needs OCGN P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OCGN FY 2025 (ended Dec 31, 2025) · CPB FY 2025 (ended Aug 3, 2025). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
OCUGEN, INC. · implied price per share
Bear
-$0.05
Base
-$0.06
Bull
-$0.07
CAMPBELL'S Co · implied price per share
Bear
$22.29
Base
$26.23
Bull
$30.16
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-2.37x
1.76x
Net debt / EBITDA
Leverage against operating earnings
-0.15x
3.35x
Cash and equivalents
Liquid reserves on the balance sheet
$19.47M
$132.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
IOVANCE BIOTHERAPEUTICS, INC.
OCGN vs IOVA
bluebird bio, Inc.
OCGN vs BLUE
BioNTech SE
OCGN vs BNTX
Moderna, Inc.
OCGN vs MRNA
Legend Biotech Corp
OCGN vs LEGN
Arcturus Therapeutics Holdings Inc.
OCGN vs ARCT
COCA COLA CO
OCGN vs KO
PEPSICO INC
OCGN vs PEP
Keysight Technologies, Inc.
OCGN vs KEYS
Mondelez International, Inc.
OCGN vs MDLZ
J M SMUCKER Co
OCGN vs SJM
Lamb Weston Holdings, Inc.
OCGN vs LW
$28.79M
$6.86B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
